{"hands_on_practices": [{"introduction": "The first crucial step in X-chromosome inactivation is the \"choice\" of which X chromosome will be silenced, a process governed by a fascinating genetic switch. This choice is determined by the antagonistic relationship between the silencing RNA, *Xist*, and its cis-acting antisense repressor, *Tsix*. This exercise [@problem_id:2865752] challenges you to apply these foundational principles to predict the outcome of a classic genetic experiment, honing your ability to reason from core biological rules to understand how this critical developmental decision is made.", "problem": "You generate a clonal line of female mouse embryonic stem cells (ESCs; pluripotent) with karyotype $XX$. On one $X$, you engineer a precise null allele of the antisense long noncoding RNA gene *Tsix* by deleting its core promoter and first exon, leaving the rest of the X-inactivation center (Xic) intact. The homologous $X$ is wild type at *Tsix* and elsewhere in the Xic. In the pluripotent state, neither $X$ expresses *Xist* RNA and both $X$ chromosomes are active. Upon induced differentiation under conditions that normally trigger random X-chromosome inactivation (XCI), you ask which $X$ is expected to become the inactive $X$ (Xi).\n\nStarting only from the following foundational principles:\n- Dosage compensation in therian mammals equalizes $X$-linked gene expression between the sexes by initiating XCI in $XX$ cells upon differentiation such that one $X$ becomes Xi while the other remains the active $X$ (Xa).\n- The long noncoding RNA *Xist* (X-inactive specific transcript) is necessary and sufficient in cis to initiate silencing of the chromosome from which it is transcribed by coating that chromosome, recruiting repressive complexes, and establishing a self-reinforcing chromatin state.\n- *Tsix* is a cis-acting antisense transcript across the *Xist* locus that antagonizes *Xist* accumulation on the same chromosome through transcriptional interference and repressive chromatin at the *Xist* promoter, thereby protecting that chromosome from becoming Xi when *Tsix* is expressed.\n- The XCI counting and choice mechanism enforces monoallelic *Xist* upregulation in $XX$ cells through thresholded activators and feedback, such that early *Xist* upregulation on one $X$ suppresses *Xist* activation on the other $X$.\n\nPredict the most likely outcome upon differentiation of these ESCs in terms of which $X$ becomes Xi and provide the mechanistic rationale for the predicted bias.\n\nChoose the single best answer.\n\nA. The *Tsix*-null $X$ is strongly predisposed to become Xi because loss of cis *Tsix*-mediated repression permits earlier and higher *Xist* upregulation in cis on that $X$, which then recruits repressive machinery, spreads across that chromosome, and, via feedback, prevents *Xist* activation on the wild-type $X$ that retains *Tsix* expression.\n\nB. The wild-type $X$ is more likely to become Xi because increased *Xist* produced from the *Tsix*-null $X$ acts in trans to target and silence the homologous chromosome, leaving the *Tsix*-null chromosome as the active $X$.\n\nC. Both $X$ chromosomes are likely to inactivate because *Tsix* loss on one $X$ globally elevates cellular *Xist* levels above the activation threshold, causing biallelic *Xist* upregulation and simultaneous inactivation of both chromosomes.\n\nD. XCI remains unbiased and approximately $50\\%$ of cells inactivate each $X$ because *Tsix* acts only after the choice step; therefore, *Tsix* deficiency does not influence which $X$ initiates *Xist* upregulation.\n\nE. Differentiation fails to trigger XCI because *Tsix* is required for counting and pairing at the Xic; without *Tsix* on one $X$, neither chromosome can initiate *Xist* and both $X$ chromosomes remain active.", "solution": "The problem statement is subjected to validation before a solution is attempted.\n\n### Step 1: Extract Givens\n- A clonal line of female mouse embryonic stem cells (ESCs) with karyotype $XX$ is generated.\n- One $X$ chromosome has a precise null allele of the antisense long noncoding RNA gene *Tsix*, created by deleting its core promoter and first exon. The rest of the X-inactivation center ($Xic$) is intact.\n- The homologous $X$ chromosome is wild type at the *Tsix* locus and elsewhere in the $Xic$.\n- In the pluripotent state, neither $X$ expresses *Xist* RNA and both $X$ chromosomes are active.\n- Differentiation is induced under conditions that normally trigger random X-chromosome inactivation (XCI).\n- The question is to predict which $X$ is expected to become the inactive $X$ (Xi).\n- The prediction must start from four foundational principles:\n    1. Dosage compensation in $XX$ cells involves inactivation of one $X$ to form an Xi, leaving the other as the active $X$ (Xa).\n    2. The long noncoding RNA *Xist* is necessary and sufficient to initiate silencing in cis on the chromosome from which it is transcribed.\n    3. *Tsix* is a cis-acting antisense transcript that antagonizes *Xist* accumulation on the same chromosome.\n    4. The XCI counting and choice mechanism enforces monoallelic *Xist* upregulation in $XX$ cells via a competitive process with feedback suppression.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded**: The problem is firmly based on established principles of molecular genetics and epigenetics, specifically the mechanism of X-chromosome inactivation in mammals. The roles of *Xist* and its antisense regulator *Tsix* are central and accurately described in the foundational principles. The experimental setup involving a targeted deletion in embryonic stem cells is a standard and valid method in the field. The problem is scientifically sound.\n- **Well-Posed**: The initial state of the system (a heterozygous *Tsix*-null cell line) is clearly defined. The process (induced differentiation) and the governing rules (the four principles) are explicitly stated. The question asks for a single, predictable outcome based on these rules. The problem is well-posed.\n- **Objective**: The problem is stated in precise, technical language, free of subjective or ambiguous terminology.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. It is scientifically sound, well-posed, objective, and complete. A solution will be derived based on the provided principles.\n\n### Derivation of Solution\nThe problem requires predicting the outcome of a competition between two non-identical $X$ chromosomes during the initiation of X-inactivation. Let us denote the wild-type chromosome as $X^{WT}$ and the chromosome with the *Tsix* deletion as $X^{\\Delta Tsix}$.\n\n1.  According to Principle 1, upon differentiation, one of the two $X$ chromosomes in each $XX$ cell must be inactivated to achieve dosage compensation. This establishes that the system must make a choice, resulting in one Xa and one Xi.\n\n2.  According to Principle 2, the chromosome that becomes the Xi is the one that successfully upregulates and accumulates *Xist* RNA. The action of *Xist* is strictly in cis, meaning it coats and silences the chromosome from which it is transcribed. Therefore, the central question is: which chromosome, $X^{WT}$ or $X^{\\Delta Tsix}$, is more likely to express *Xist*?\n\n3.  According to Principle 3, *Tsix* RNA acts in cis to antagonize *Xist* accumulation. It functions as a repressor of *Xist* on the same chromosome.\n    - On the $X^{WT}$ chromosome, the *Tsix* gene is functional. Upon the onset of differentiation, *Tsix* will be expressed and will actively work to suppress the upregulation of *Xist* at the $X^{WT}$ locus.\n    - On the $X^{\\Delta Tsix}$ chromosome, the *Tsix* gene is non-functional due to the deletion of its promoter and first exon. Consequently, there is no *Tsix*-mediated antagonism of *Xist* expression from this chromosome.\n\n4.  According to Principle 4, the choice of which $X$ to inactivate is a competitive process resolved by a feedback mechanism. Both chromosomes are initially susceptible to *Xist* upregulation. However, the chromosome that first surpasses a threshold of *Xist* expression \"wins\" the competition. This \"winning\" choice triggers two events: (i) stable and high-level *Xist* expression on the chosen chromosome, leading to its inactivation, and (ii) a feedback signal that actively prevents *Xist* upregulation on the other chromosome, ensuring it remains active.\n\n5.  Synthesizing these principles leads to a clear prediction. The competition for *Xist* upregulation is heavily skewed. On the $X^{\\Delta Tsix}$ chromosome, *Xist* expression is unopposed by its primary cis-acting antagonist, *Tsix*. On the $X^{WT}$ chromosome, *Xist* expression is actively repressed by *Tsix*. Therefore, the probability of *Xist* transcription initiating and accumulating to the required threshold is vastly higher on the $X^{\\Delta Tsix}$ chromosome. This chromosome will almost certainly \"win\" the competition in every cell.\n\n6.  Once the $X^{\\Delta Tsix}$ chromosome begins to robustly express *Xist*, it will coat itself in cis (Principle 2) and become the Xi. Simultaneously, the feedback mechanism (Principle 4) will suppress any nascent *Xist* expression on the $X^{WT}$ chromosome, ensuring it becomes the Xa.\n\nThe predicted outcome is a strongly biased, or non-random, X-inactivation, where the *Tsix*-null chromosome ($X^{\\Delta Tsix}$) is consistently chosen as the inactive $X$ (Xi).\n\n### Evaluation of Options\n\n**A. The *Tsix*-null $X$ is strongly predisposed to become Xi because loss of cis *Tsix*-mediated repression permits earlier and higher *Xist* upregulation in cis on that $X$, which then recruits repressive machinery, spreads across that chromosome, and, via feedback, prevents *Xist* activation on the wild-type $X$ that retains *Tsix* expression.**\nThis statement correctly identifies the `*Tsix*`-null $X$ as the future $Xi$. It accurately describes the mechanism: the absence of *Tsix*-mediated repression in cis allows for more robust *Xist* upregulation on the mutant chromosome. This initial advantage is then locked in by the competitive choice and feedback mechanism, which silences *Xist* on the wild-type $X$. The entire causal chain is consistent with the provided principles.\n**Verdict: Correct**\n\n**B. The wild-type $X$ is more likely to become Xi because increased *Xist* produced from the *Tsix*-null $X$ acts in trans to target and silence the homologous chromosome, leaving the *Tsix*-null chromosome as the active $X$.**\nThis option makes a fundamental error. Principle 2 explicitly states that *Xist* acts in cis to silence the chromosome from which it is transcribed. It does not act in trans to silence the other chromosome. Therefore, the *Xist* produced from the *Tsix*-null $X$ will inactivate the *Tsix*-null $X$, not the wild-type $X$.\n**Verdict: Incorrect**\n\n**C. Both $X$ chromosomes are likely to inactivate because *Tsix* loss on one $X$ globally elevates cellular *Xist* levels above the activation threshold, causing biallelic *Xist* upregulation and simultaneous inactivation of both chromosomes.**\nThis contradicts Principle 1, which establishes that dosage compensation requires one active and one inactive $X$, and Principle 4, which states that the choice mechanism enforces *monoallelic* *Xist* upregulation. The inactivation of both $X$ chromosomes is a lethal event that the cellular machinery for XCI is designed to prevent.\n**Verdict: Incorrect**\n\n**D. XCI remains unbiased and approximately $50\\%$ of cells inactivate each $X$ because *Tsix* acts only after the choice step; therefore, *Tsix* deficiency does not influence which $X$ initiates *Xist* upregulation.**\nThis statement is factually incorrect based on the provided principles. Principle 3 describes *Tsix* as an antagonist to *Xist* accumulation. Principle 4 describes choice as a competitive process. The antagonism of *Xist* by *Tsix* is integral to biasing this competition. By removing *Tsix* from one chromosome, the competition is made decisively unfair. Thus, *Tsix* acts *at the core of* the choice mechanism, not after it. The inactivation will be highly skewed, not random.\n**Verdict: Incorrect**\n\n**E. Differentiation fails to trigger XCI because *Tsix* is required for counting and pairing at the Xic; without *Tsix* on one $X$, neither chromosome can initiate *Xist* and both $X$ chromosomes remain active.**\nThis option assigns a role to *Tsix* (in counting/pairing) not specified in the foundational principles and makes an illogical conclusion. The provided role for *Tsix* is as an antagonist of *Xist* (Principle 3). Deleting an antagonist should facilitate, not block, the process it antagonizes. Therefore, loss of *Tsix* is expected to promote *Xist* upregulation, not prevent it. The outcome of two active $X$ chromosomes would also violate Principle 1.\n**Verdict: Incorrect**", "answer": "$$\\boxed{A}$$", "id": "2865752"}, {"introduction": "Once an X chromosome is chosen for inactivation, the *Xist* RNA must execute the silencing program by acting as a molecular scaffold. *Xist* is not a monolithic entity but a modular platform where distinct domains perform different tasks, such as localizing to the chromosome versus recruiting specific protein complexes to repress transcription. By analyzing the effect of deleting a specific functional module like Repeat A [@problem_id:2865761], you will practice structure-function reasoning and appreciate how long non-coding RNAs orchestrate complex molecular events.", "problem": "A researcher uses Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) to engineer a precise deletion of the conserved Repeat A element from the long noncoding RNA X-inactive specific transcript (*Xist*) in female mouse embryonic stem cells, leaving the promoter and other repeat regions of *Xist* intact. Upon differentiation, the researcher assays two features in parallel: (i) the ability of *Xist* RNA to coat and remain localized in cis over the X chromosome territory, and (ii) the ability of *Xist* to initiate transcriptional silencing across X-linked genes.\n\nReason from first principles appropriate to the principles of genetics, using only well-established foundational facts, including: the Central Dogma (DNA to RNA to protein), the modular nature of long noncoding RNA domains in recruiting protein effectors, the requirement for exclusion of RNA Polymerase II (RNAPII) and repressive chromatin remodeling to achieve gene silencing, and the role of Polycomb Repressive Complexes in depositing repressive histone marks. Consider that distinct *Xist* repeat modules recruit different effectors (for example, engagement of a Split ends homolog (SPEN, also known as SHARP) and histone deacetylase 3 (HDAC3) versus recruitment of Polycomb Repressive Complexes by other repeats), and that cis-localization and nuclear compartmentalization of *Xist* involve additional sequence elements.\n\nWhich of the following outcomes best captures the expected phenotype of the Repeat A deletion with respect to these two features?\n\nA. Both features fail: *Xist* does not form a chromosome-associated nuclear cloud and cannot localize in cis, and transcriptional silencing nevertheless proceeds via alternative pathways.\n\nB. *Xist* coating and cis-localization are largely preserved, and Polycomb recruitment through other repeats can still occur, but initiation of transcriptional silencing is severely compromised due to loss of SPEN/HDAC3 engagement.\n\nC. *Xist* coating is defective, but once localized the remaining repeats suffice to drive robust transcriptional silencing primarily through Polycomb, resulting in near-normal repression.\n\nD. Neither feature is detectably affected because functional redundancy across repeats compensates for the loss of Repeat A.\n\nE. *Xist* coating and localization are enhanced by the deletion of a silencing module, and transcriptional silencing shows only a transient delay during the first $24$ hours of differentiation before fully recovering.", "solution": "The problem statement will first be subjected to a rigorous validation procedure.\n\n**Step 1: Extract Givens**\n-   **System**: Female mouse embryonic stem cells.\n-   **Genetic Modification**: Precise deletion of the conserved Repeat A element from the long noncoding RNA X-inactive specific transcript (*Xist*) using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated protein 9 (Cas9).\n-   **Preserved Elements**: The promoter and other repeat regions of *Xist* remain intact.\n-   **Assayed Features**: Upon cell differentiation, two features are measured:\n    1.  The ability of *Xist* RNA to coat and remain localized in *cis* over the X chromosome territory.\n    2.  The ability of *Xist* to initiate transcriptional silencing across X-linked genes.\n-   **Foundational Principles**:\n    -   The Central Dogma (DNA to RNA to protein).\n    -   The modular nature of long noncoding RNA domains in recruiting protein effectors.\n    -   Requirement for exclusion of RNA Polymerase II (RNAPII) and repressive chromatin remodeling for gene silencing.\n    -   Role of Polycomb Repressive Complexes in depositing repressive histone marks.\n    -   Distinct *Xist* repeat modules recruit different effectors (e.g., Split ends homolog (SPEN) and histone deacetylase 3 (HDAC3) by one module, Polycomb Repressive Complexes by others).\n    -   *Cis*-localization and nuclear compartmentalization of *Xist* involve additional sequence elements.\n\n**Step 2: Validate Using Extracted Givens**\n-   **Scientific Grounding**: The problem is based on established principles of molecular genetics and epigenetics. The function of the lncRNA *Xist*, its modular structure, the process of X-chromosome inactivation, and the roles of specific protein complexes like SPEN, HDAC3, and Polycomb are all subjects of extensive and well-founded scientific research. The experimental setup using CRISPR/Cas9 in embryonic stem cells is a standard and scientifically realistic approach. The problem is scientifically sound.\n-   **Well-Posedness**: The problem defines a specific genetic perturbation (deletion of Repeat A) in a well-defined biological system (female mouse ES cells) and asks for the resulting phenotype concerning two specific, measurable outcomes (localization and silencing). Given the established, non-redundant roles of *Xist* domains, a unique and meaningful solution is determinable.\n-   **Objectivity**: The problem is stated in precise, technical language, free from subjective or ambiguous terminology.\n-   **Completeness and Consistency**: The problem provides sufficient information and guiding principles to logically deduce the outcome. It explicitly states that *Xist* is modular and that different elements are responsible for localization versus recruitment of specific silencing factors. This information is internally consistent and adequate for forming a conclusion.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. It is scientifically grounded, well-posed, and contains sufficient information to proceed to a solution.\n\n**Solution Derivation**\nThe process of X-chromosome inactivation (XCI) is orchestrated by the *Xist* lncRNA. *Xist* functions by coating the X chromosome from which it is transcribed (*in cis*) and subsequently recruiting a series of protein complexes that modify chromatin structure to achieve transcriptional silencing. The problem requires reasoning based on the modular nature of the *Xist* RNA.\n\n1.  **Xist Transcription and Localization**: The problem states the *Xist* promoter is intact. Therefore, upon differentiation, the *Xist* gene will be transcribed, producing a mutant RNA lacking the Repeat A element. The problem also specifies that *cis*-localization and compartmentalization involve \"additional sequence elements\" distinct from the one being deleted. Experimental evidence has shown that elements in the $3'$ region of the *Xist* transcript, as well as other repeats, are critical for its spreading and localization to the X chromosome territory. Deletion of Repeat A alone is not known to abrogate the ability of *Xist* to paint the chromosome. Therefore, it is expected that the mutant *Xist* RNA will still largely succeed in coating the X chromosome in *cis*. This addresses the first assayed feature.\n\n2.  **Initiation of Transcriptional Silencing**: The problem directs us to consider that distinct repeat modules recruit different effectors, giving the example of SPEN/HDAC3 versus Polycomb complexes. The Repeat A element of *Xist* is the specific module responsible for recruiting the protein SPEN (also known as SHARP). SPEN is an essential factor for initiating gene silencing. It functions by recruiting the NCoR/SMRT co-repressor complex, which contains histone deacetylase 3 (HDAC3). The enzymatic activity of HDAC3 removes acetyl groups from histone tails, which is a primary and necessary step for compacting chromatin, excluding RNA Polymerase II (RNAPII) from gene promoters, and thus silencing transcription.\n\n3.  **Consequence of Repeat A Deletion**: By deleting Repeat A, the primary binding platform for SPEN is removed from the *Xist* RNA. Consequently, SPEN and its associated HDAC3 complex will not be recruited to the X chromosome. The failure to recruit HDAC3 means that the initial wave of histone deacetylation will not occur. This is a catastrophic failure for the *initiation* of gene silencing.\n\n4.  **Role of Other Modules**: The other repeats of *Xist*, which are intact, are responsible for recruiting other factors, such as the Polycomb Repressive Complexes (PRC1 and PRC2). These complexes deposit repressive histone marks (e.g., H2AK119ub1 and H3K27me3) that are critical for the establishment and maintenance of the silenced state. However, the recruitment of Polycomb complexes and the deposition of their associated marks are events that typically occur *after* the initial silencing has been triggered by the SPEN/HDAC3 pathway. While these other repeats are functional, they cannot compensate for the loss of the essential initiation step mediated by Repeat A. The Polycomb system alone is insufficient to initiate robust, chromosome-wide silencing.\n\n**Conclusion**: The expected phenotype for the Repeat A deletion is that *Xist* RNA will still be able to coat the X chromosome, but it will be unable to efficiently initiate transcriptional silencing due to the failure to recruit the SPEN/HDAC3 machinery.\n\n**Option-by-Option Analysis**\n-   **A. Both features fail: *Xist* does not form a chromosome-associated nuclear cloud and cannot localize in cis, and transcriptional silencing nevertheless proceeds via alternative pathways.**\n    This option is incorrect. Localization is not primarily dependent on Repeat A and should be largely preserved. The claim that silencing \"proceeds via alternative pathways\" is unsubstantiated and contradicts the central, initiating role of the pathway being disrupted.\n\n-   **B. *Xist* coating and cis-localization are largely preserved, and Polycomb recruitment through other repeats can still occur, but initiation of transcriptional silencing is severely compromised due to loss of SPEN/HDAC3 engagement.**\n    This option is correct. It accurately describes the expected outcome based on the distinct, modular functions of *Xist* repeats. Localization (coating) is preserved because other elements mediate it. The core defect is a failure in silencing *initiation* due to the inability to recruit SPEN/HDAC3 via the deleted Repeat A, a defect that cannot be fully compensated for by the later-acting Polycomb machinery.\n\n-   **C. *Xist* coating is defective, but once localized the remaining repeats suffice to drive robust transcriptional silencing primarily through Polycomb, resulting in near-normal repression.**\n    This option is incorrect. It incorrectly states that coating is defective. More significantly, it falsely claims that Polycomb complexes alone are sufficient to drive robust silencing, which contradicts the established requirement for the SPEN/HDAC3 pathway in initiating silencing.\n\n-   **D. Neither feature is detectably affected because functional redundancy across repeats compensates for the loss of Repeat A.**\n    This option is incorrect. It invokes functional redundancy, which is contrary to the known specific and essential role of Repeat A in recruiting SPEN. The modular nature of *Xist* implies specialized, non-redundant functions for its domains.\n\n-   **E. *Xist* coating and localization are enhanced by the deletion of a silencing module, and transcriptional silencing shows only a transient delay during the first $24$ hours of differentiation before fully recovering.**\n    This option is incorrect. There is no logical or established basis for the claim that deleting a functional module would \"enhance\" localization. The role of Repeat A is fundamental to initiation, and its loss would cause a persistent, severe defect, not a transient delay.", "answer": "$$\\boxed{B}$$", "id": "2865761"}, {"introduction": "The silencing initiated by *Xist* is not transient; it must be stably inherited through cell division, which is achieved by establishing a repressive chromatin environment. The level of key histone modifications, such as H3K27 trimethylation, can be understood as a dynamic steady state resulting from the balanced activities of \"writer\" enzymes like PRC2 and \"eraser\" enzymes. This quantitative practice [@problem_id:2865748] allows you to model these epigenetic dynamics using first-order kinetics, providing a powerful framework to predict how the silent state is established and how it might be perturbed by therapeutic inhibitors.", "problem": "In female mammalian cells, X-chromosome inactivation (XCI) is initiated by the X-inactive specific transcript (*Xist*) long non-coding RNA, which coats the future inactive X-chromosome and recruits Polycomb Repressive Complex 2 (PRC2) to catalyze histone H3 lysine 27 trimethylation (H3K27me3). Consider a homogeneous domain of nucleosomes on the inactive X-chromosome that can exist in one of two states: unmodified ($U$) or H3K27me3-modified ($M$). Assume first-order kinetics for transitions between these states driven by a methylation addition process with rate constant $k_{\\text{add}}$ (mediated by PRC2 recruited by Xist) and an erasure process with rate constant $k_{\\text{erase}}$ (mediated by demethylases and effective dilution by replication). Let $\\theta(t)$ denote the fraction of nucleosomes in state $M$ at time $t$, and assume a well-mixed domain and independence among nucleosomes.\n\nStarting from standard two-state first-order kinetics and the principle that, at steady state, the net probability flux into and out of state $M$ balances, derive an expression for the steady-state occupancy $\\theta^{\\ast}$ of H3K27me3 in terms of $k_{\\text{add}}$ and $k_{\\text{erase}}$. Then apply your expression to the following scenario: before intervention, the inactive X-chromosome domain exhibits an addition rate $k_{\\text{add}}^{(0)} = 1.2\\,\\mathrm{h}^{-1}$ and an erasure rate $k_{\\text{erase}} = 0.3\\,\\mathrm{h}^{-1}$. A selective PRC2 catalytic inhibitor reduces the effective addition rate to a fraction $\\alpha = 0.25$ of its baseline value while leaving $k_{\\text{erase}}$ unchanged. Compute the predicted post-inhibition steady-state occupancy $\\theta_{\\text{inhib}}^{\\ast}$ as a decimal fraction. Round your final numeric answer to four significant figures and report it without units.", "solution": "We model the nucleosome modification dynamics as a two-state Markov process with states $U$ (unmodified) and $M$ (H3K27me3-modified). Let $\\theta(t)$ be the fraction of nucleosomes in state $M$ at time $t$, so that $1-\\theta(t)$ is the fraction in state $U$. Under first-order kinetics, the gain of $M$ arises from addition at rate $k_{\\text{add}}$ acting on unmodified nucleosomes, and the loss of $M$ arises from erasure at rate $k_{\\text{erase}}$ acting on modified nucleosomes. The time evolution is therefore\n$$\n\\frac{d\\theta}{dt} \\;=\\; k_{\\text{add}} \\left(1 - \\theta\\right) \\;-\\; k_{\\text{erase}} \\,\\theta.\n$$\nAt steady state, the occupancy $\\theta^{\\ast}$ satisfies $\\frac{d\\theta}{dt}=0$, which enforces a balance of probability fluxes into and out of state $M$:\n$$\n0 \\;=\\; k_{\\text{add}} \\left(1 - \\theta^{\\ast}\\right) \\;-\\; k_{\\text{erase}} \\,\\theta^{\\ast}.\n$$\nRearranging,\n$$\nk_{\\text{add}} \\;=\\; \\left(k_{\\text{add}} + k_{\\text{erase}}\\right)\\theta^{\\ast},\n$$\nand thus\n$$\n\\theta^{\\ast} \\;=\\; \\frac{k_{\\text{add}}}{k_{\\text{add}} + k_{\\text{erase}}}.\n$$\nThis expression reflects the intuitive steady-state balance: the occupancy equals the fraction of total transition hazard directed into the modified state.\n\nWe now apply this to the PRC2 inhibition scenario. Baseline parameters are $k_{\\text{add}}^{(0)} = 1.2\\,\\mathrm{h}^{-1}$ and $k_{\\text{erase}} = 0.3\\,\\mathrm{h}^{-1}$. The inhibitor scales the addition rate by a factor $\\alpha = 0.25$, so the post-inhibition addition rate is\n$$\nk_{\\text{add}}^{(\\text{inhib})} \\;=\\; \\alpha\\, k_{\\text{add}}^{(0)} \\;=\\; 0.25 \\times 1.2\\,\\mathrm{h}^{-1} \\;=\\; 0.3\\,\\mathrm{h}^{-1}.\n$$\nThe predicted post-inhibition steady-state occupancy is therefore\n$$\n\\theta_{\\text{inhib}}^{\\ast} \\;=\\; \\frac{k_{\\text{add}}^{(\\text{inhib})}}{k_{\\text{add}}^{(\\text{inhib})} + k_{\\text{erase}}} \\;=\\; \\frac{0.3}{0.3 + 0.3} \\;=\\; \\frac{0.3}{0.6} \\;=\\; 0.5.\n$$\nRounded to four significant figures and expressed as a decimal fraction without units, the result is $0.5000$.", "answer": "$$\\boxed{0.5000}$$", "id": "2865748"}]}